The first platform to allow phenotypic resistance testing directly from polymicrobial clinical samples containing commensal flora, and not just “directly from positive blood cultures”
The only introduced platform capable of decentralized resistance testing and antibiotic susceptibility testing (AST)
It is widely known that phenotypic resistance testing offers more reliable results than genotypic testing
No compromise between assay sensitivity and result time
Applies the same fully automated and field proven TPX technology as the CE marked mariPOC®
mariAST®results allow you to take the right decisions
Pathogen- and strain-specific diagnosis and treatment
Accurate use of antimicrobials
Precise in-patient cohorting and fast discharge of contact isolation measures
Improved cost-effectiveness and patient flow management
What applications mariAST® is suitable for?
The technology provides most added value when the time to result matters, the number of plausible pathogens is limited and testing breakpoint antimicrobial concentration is enough
For example MRSA screening and testing, sexually transmitted diseases and non-penicillin susceptible pneumococci
Technically mariAST® enables also determination of MICs
